NYRA
nyra health GmbH provides innovative, evidence-based neurological therapy solutions to make treatment accessible to everyone, utilized in over 100 clinics.
Classification
Profile
Funding
Funding details not yet available.
Accessible, evidence-based neurological therapy solutions that help patients regain daily life through innovative, clinically validated tools.
Clinical institutions (over 100 clinics) and patients, serving a user base of over 40 million people.
Free for patients; B2B enterprise model for clinics. Specific pricing structure is not disclosed in the snippets.
Direct integration into clinical workflows across partner hospitals and clinics.
Over 100 clinical institutions and healthcare partners who trust and utilize their solutions daily.
R&D for evidence-based therapeutic solutions; platform maintenance; clinical partnership management.
Proprietary evidence-based therapeutic technology, clinical expertise, and a large user base of 40 million.
Developing innovative neurological therapy solutions and maintaining clinical partnerships for daily deployment.
B2B2C model relying on clinical trust and integration within hospital systems rather than direct consumer sales.
Competes in the neurological rehabilitation sector, differentiating through evidence-based innovation and widespread clinical adoption.
Rising prevalence of neurological diseases (projected 50% increase by 2050) and limited access to effective neurological rehabilitation.
- Accelerate US Market Entry
The MDR Class IIa certification and multiple RCT publications provide a solid clinical foundation, reducing adoption risk for hospitals and · Series A €20 M funding from reputable venture partners validates market confidence and supplies runway for EU-US expansion
No investors recorded yet.